TEDA Tianjin, China, September 4, 2009:
Asymchem Life Science (Tianjin) Co. Ltd., a wholly-owned subsidiary of Asymchem Laboratories Inc., a leading research-based contract manufacturer of API’s and intermediates and Drug Products to the pharmaceutical industry, is pleased to issue the final confirmed list of speakers for the upcoming Fall Symposium in Process Chemistry held in Asymchem Life Science in TEDA Tianjin, P.R. China, from October 17-19, 2009.
Company and Academic speakers to present at Asymchem’s Fall Process Chemistry Symposium Oct 17-19, 2009:
|
No. |
Company |
Speaker |
Title |
Topic |
|
1 |
Merck |
Joe Armstong |
Senior Dir.,
Process Research |
Innovation as the Driver of
Green Chemistry Advances
in the Pharmaceutical Industry |
|
2 |
Lilly |
Hannah Yu |
Principal Research
Scientist |
Development of an Efficient
Palladium-Catalyzed Intramolecular
Carbometalation Reaction for the
Synthesis of a Dibenzoxapine
Containing Tetrasubstituted
Exocyclic Alkene |
|
3 |
Pfizer |
Yousef Hajikarimian |
Principal Scientist |
Evolution of the manufacturing
process to UK-369,003-26 / a
PDE5 inhibitor for treatment
of multiple indications |
|
4 |
Pfizer |
Matt Birchmeieran
and
Brian Chekal |
Physical properties
ScientistPrincipal
Scientist |
Crystallization: Theory, Methods,
and Analyses |
|
5 |
Lexicon |
Winston Wu |
Senior Dir,
Chemical
Development |
Process Chemistry in a
Small Biotech Company:
A Case Study |
|
6 |
BMS |
Mauricio Futran |
VP, Process R&D |
API and Intermediates Outsourcing:
The Changing Value Proposition
for Suppliers |
|
7 |
BMS |
Stephen Scypinski |
VP, Analytical R&D |
Pharmaceutical Analysis in
the 21st Century:
New Challenges and
New Solutions |
|
8 |
Lilly |
Scott Bradley |
Scientist |
NMR-based Reaction Monitoring:
From Small Molecules to Biologics |
|
9 |
Roche |
Yi Ren |
Head of Drug
Supply and
Discovery
Technology |
Process Research of a Glucose
Kinase Activator for the Treatment
of Type-II Diabetes |
|
10 |
University
of Wisconsin |
Richard Hsung |
Professor |
Total Synthesis of Phomactin A. |
|
11 |
University
of Liverpool |
Andy Evans |
Professor |
New Asymmetric Methods for
Heterocyclic Synthesis – Total
Synthesis of Marinomycin A |
|
12 |
North Dakota
State University |
Muk Sibi |
Professor |
Chiral Lewis and Brønsted Acid
Catalysis: Exploration of
Asymmetric Transformations |
|
13 |
Swiss Federal
Institute
of Technology |
Erick Carreira |
Professor |
Surprises and Discoveries
with Natural Products |
|
14 |
West Virginia University |
George O'Doherty |
Asst Professor |
De Novo Synthesis
in Carbohydrate Chemistry |
|
15 |
AstraZeneca |
Andy Wells |
Lead principal scientist |
Some applications
of Biocatalysis in the Synthesis
of pharmaceuticals -present practice and future trends |
|
16 |
North Carolina
State University |
Dan Comins |
Professor |
Chiral Heterocycles
as Synthetic Intermediates
|
|
17 |
Colorado State University |
Yi-An Shi |
professor |
Organo and Metallocatalytic
Oxidation of Olefins |
|
18 |
Shanghai Institute
of Organic Chemistry |
Biao Yu |
Professor
and Associate
Director |
Synthesis of Complex
Glycoconjugates
of Biological Significance |
“We are pleased to bring together industrial and academic experts in the field of process chemistry and synthetic organic chemistry for a 3-day event”, says Dr. Hao Hong, President and CEO of Asymchem. “The symposium will showcase new developments in the process field and provide a forum of discussion as to the state of the API contract R&D and manufacturing business in China, with a direct view into one of the key suppliers at the forefront.”
Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API’s and Drug Products serving the pharmaceutical industry. With a 14yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information,
please visit the Asymchem website at http://fallsymposium.asymchem.com/